Evidence map›Paper›PMID 33318207›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Inhibition of GCK-IV kinases dissociates cell death and axon regeneration in CNS neurons.

Amit K Patel, Risa M Broyer, Cassidy D Lee, Tianlun Lu, Mikaela J Louie, Anna La Torre, Hassan Al-Ali, Mai T Vu, Katherine L Mitchell, Karl J Wahlin and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. American journal of physiology. Renal physiology · 2024
    Article
  13. Review
  14. Mesenchymal stem cells for repairing glaucomatous optic nerve.International journal of ophthalmology · 2024
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Amit K PatelViterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA 92093.
Risa M BroyerViterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA 92093.ORCID 0000-0002-5045-8429
Cassidy D LeeViterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA 92093.
Tianlun LuViterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA 92093.
Mikaela J LouieDepartment of Cell Biology and Human Anatomy, University of California, Davis, CA 95616.ORCID 0000-0002-5673-8560
Anna La TorreDepartment of Cell Biology and Human Anatomy, University of California, Davis, CA 95616.ORCID 0000-0003-2103-4376
Hassan Al-AliTruvitech LLC, Miami, FL 33136.
Mai T VuViterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA 92093.ORCID 0000-0003-3865-4918
Katherine L MitchellWilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287.ORCID 0000-0002-3112-487X
Karl J WahlinViterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA 92093.ORCID 0000-0002-0494-8304
Cynthia A BerlinickeWilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287.
Vinod Jaskula-RangaWilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287.ORCID 0000-0003-1202-634X
Yang HuDepartment of Ophthalmology, Stanford University, Stanford, CA 94304.ORCID 0000-0002-7980-1649
Xin DuanDepartment of Ophthalmology, University of California, San Francisco, CA 94158.
Santiago VilarTruvitech LLC, Miami, FL 33136.
John L BixbyThe Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami, Miami, FL 33136.ORCID 0000-0003-1633-5318
Robert N WeinrebViterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA 92093.
Vance P LemmonTruvitech LLC, Miami, FL 33136.ORCID 0000-0003-3550-7576
Donald J ZackWilmer Eye Institute, Johns Hopkins University, Baltimore, MD 21287.ORCID 0000-0002-7966-1973
Derek S WelsbieViterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA 92093; dwelsbie@ucsd.edu.
University of California San Diego · USJohns Hopkins University · USUniversity of Miami · USUniversity of California, Davis · USStanford University · USUniversity of California, San Francisco · US

Funding

Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Derek Stuart Welsbie · 2012 to 2026
$10.3M
Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve RegenerationR01EY024932 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI Yang Hu · 2015 to 2026
$4.8M
Neuroprotection by Modulating ER Stress in GlaucomaR01EY023295 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI HU, YANG · 2013 to 2022
$3.8M
Mechanisms Underlying Type II Cadherin Guided Assembly of Retinal CircuitsR01EY030138 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Xin Duan · 2020 to 2026
$3.2M
Kinase Multitargeting for Glaucoma NeuroprotectionR01EY029342 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Derek Stuart Welsbie · 2018 to 2026
$3.2M
Pluripotent Stem Cell Derived 3D Retinas for Studies of Early Onset Retinal DegenerationR01EY031318 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WAHLIN, KARL J · 2020 to 2024
$2.4M
Embryonic Stem Cell Approach to Retinal Ganglion Cell Replacement: an In Vivo StudyR01EY026942 · NEI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LA TORRE, ANNA · 2016 to 2020
$2.0M
Developing Novel Neuroprotective Strategies for EAE/Optic NeuritisR01EY028106 · NEI · STANFORD UNIVERSITY · PI HU, YANG · 2018 to 2021
$1.9M
Modeling Photoreceptor Development and Disease Using Human Pluripotent Stem CellsR00EY024648 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WAHLIN, KARL J · 2016 to 2018
$778k
NEI NIH HHS P30 EY022589NEI NIH HHS P30 EY026877NEI NIH HHS R00 EY024648NEI NIH HHS R01 EY023295NEI NIH HHS R01 EY024932NEI NIH HHS R01 EY026942NEI NIH HHS R01 EY028106NEI NIH HHS R01 EY029342NEI NIH HHS R01 EY030138NEI NIH HHS R01 EY031318
6 · The paper itself

Abstract

Axon injury is a hallmark of many neurodegenerative diseases, often resulting in neuronal cell death and functional impairment. Dual leucine zipper kinase (DLK) has emerged as a key mediator of this process. However, while DLK inhibition is robustly protective in a wide range of neurodegenerative disease models, it also inhibits axonal regeneration. Indeed, there are no genetic perturbations that are known to both improve long-term survival and promote regeneration. To identify such a neuroprotective target, we conducted a set of complementary high-throughput screens using a protein kinase inhibitor library in human stem cell-derived retinal ganglion cells (hRGCs). Overlapping compounds that promoted both neuroprotection and neurite outgrowth were bioinformatically deconvoluted to identify specific kinases that regulated neuronal death and axon regeneration. This work identified the role of germinal cell kinase four (GCK-IV) kinases in cell death and additionally revealed their unexpected activity in suppressing axon regeneration. Using an adeno-associated virus (AAV) approach, coupled with genome editing, we validated that GCK-IV kinase knockout improves neuronal survival, comparable to that of DLK knockout, while simultaneously promoting axon regeneration. Finally, we also found that GCK-IV kinase inhibition also prevented the attrition of RGCs in developing retinal organoid cultures without compromising axon outgrowth, addressing a major issue in the field of stem cell-derived retinas. Together, these results demonstrate a role for the GCK-IV kinases in dissociating the cell death and axonal outgrowth in neurons and their druggability provides for therapeutic options for neurodegenerative diseases.

Indexed as

Nerve RegenerationAnimalsAxonsBase SequenceCell DeathCell SurvivalCentral Nervous SystemCRISPR-Cas SystemsDependovirusDisease Models, AnimalGerminal Center KinasesHumansMice, Inbred C57BLNeuronal OutgrowthOptic Nerve InjuriesOrganoidsGerminal Center KinasesProtein Kinase Inhibitorsaxon regenerationGCK-IV kinasesneuroprotection

Identifiers

PMID33318207
PMCPMC7777023
OpenAlexW3110648524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.